Step 1 of
Step 2 of
Step 3 of
Step 17 of
All Categories chevron icon Imaging Systems chevron icon Imaging Software chevron icon PACS

Radiology Solutions
Filtered view: (Large - 300K+ Studies)

Subject Expert
Monique Rasband
VP of Imaging & Oncology
KLAS VP of Imaging & Oncology - Monique Rasband
 
Step 16 of
  Read User Comments
Step 15 of
 Compare Products
View Advanced Filters
Step 14 of

Trending Filters

By Years
1
2
3

Featured  Reports

PACS 2025: Consistent Support & Ongoing Product Development Are Key to Customer Success
PACS 2025:
Consistent Support & Ongoing Product Development Are Key to Customer Success
April 2025
View Report
Imaging in the Cloud 2024: Which Vendors Are Perceived as Ready for the Cloud?
View Report

Preferences

Add Bookmark   Bookmark

Does this page look different?
Get a summary of what's new.
Get a tour.



Overall Score    Filtered view: (Large - 300K+ Studies) ##.#   Segment Average ##.#

Average for PACS ##.#
50
 
100
Software Average for KLAS Rated Products ##.#

Single Physician

The product does not have 15 surveys from facilities with 2-10 physicians, but has at least 15 when including surveys from single physician facilities.

Component

Solution that typically includes most but not all components that comprise a complete system or that serves only a subset of the market.

Limited market share

This solution does not have a sufficient number of live customers to qualify for a Best in KLAS ranking.

Not primary

Solution is not the vendor’s lead product in the category but may still be purchased.

Regional

Solution for which the majority of data comes from organizations located in the same, small geographical area.

Superseded

Legacy solutions or other solutions that are not generally marketed or whose marketing is superseded by another solution in the same category.

Emerging technology

Solution is new/emerging and has yet to meet standard data level qualifications. Designation will be removed once solution meets the qualifications.

Market Energy

This is an indication of the relative considerations of Market Energy within the shown products from the

Decision Insights KLAS Data

Market Energy Levels:

Low Market Energy
Medium Market Energy
High Market Energy
Not Enough Data

Org Sample Size

  • n = total survey sample size
  • u = # of unique organizations surveyed
Step 4 of
Step 5 of

Overall Score Trending (1 Year) Filtered view: (Large - 300K+ Studies)

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.
Step 6 of

Latest Comments    See all (50) comments Filtered view: (Large - 300K+ Studies) ##.#% ##.#% ##.#%  Download as Excel

Step 7 of
Step 8 of
Question detail loading... loading
Step 9 of
Step 10 of
Step 11 of
Score Distribution
 
 
 Mean
9
##.#%
8
##.#%
7
##.#%
6
##.#%
5
##.#%
4
##.#%
3
##.#%
2
##.#%
1
##.#%
Facility Type
 
 
Standalone Facilities
Multi-site Facilities
7%
93%

Step 12 of
Step 13 of
 Download as Excel  Print / Save as PDF
View All Reports
Related Reports
Perception
KLAS article icon
Imaging in the Cloud 2024
04 June 24    |   Monique Rasband and Sidney Tate
The healthcare imaging market in the US is moving to the cloud—nearly two-thirds of the 228 healthcare organizations surveyed about their cloud road map either are using the cloud for diagnostic image viewing and/or storage or are likely to start using the cloud within the next three years. As organizations transition, it is critical for them to choose a vendor that provides not only a reliable cloud solution but also strategic guidance to ensure a successful migration. Intended to help organizations considering the cloud, this report shares customer perceptions of their vendors’ readiness for the cloud, along with an overview of the state of cloud adoption in the imaging market.
Perception
KLAS article icon
Optum/Change Healthcare Merger
16 August 22    |   Boyd Stewart and Sam Eaquinto
In January 2021, Optum announced their intentions to acquire Change Healthcare. The merger remains unfinalized, however, as the US Department of Justice blocked the deal in February 2022 due to anticompetition concerns—such a merger would give UnitedHealth Group, Optum’s parent company and the nation’s largest insurer, access to rivals’ sensitive data. The legal proceeding is ongoing and scheduled to go to trial August 1, 2022. This report shares Optum and Change Healthcare customers’ reactions to the merger and their perceptions of its impact. Between March 2021 and April 2022, KLAS interviewed 48 individuals from 46 unique organizations; of these respondents, 9% are Optum customers, 56% are Change Healthcare customers, and 35% are customers of both vendors.
,
We use cookies! We use essential and basic aggregated, depersonalized Google Analytics cookies to provide the type of content which our visitors are most interested in.  Cookie Policy    
​